1500 studies found for:    Open Studies | "Eye Diseases"
Show Display Options
Rank Status Study
1 Recruiting Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)
Conditions: Thyroid Associated Ophthalmopathies;   Graves´ Ophthalmopathy;   Thyroid Eye Disease
Interventions: Drug: Tocilizumab (RoActemra®);   Drug: Sterile 0.9% Sodium Chloride
2 Recruiting Teprotumumab Treatment in Patients With Active Thyroid Eye Disease
Conditions: Thyroid Associated Ophthalmopathies;   Thyroid-Associated Ophthalmopathy
Interventions: Drug: teprotumumab;   Drug: Placebo
3 Recruiting Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
Conditions: Primary Sjogren Syndrome;   Secondary Sjogren Syndrome;   Aqueous Deficient Dry Eye Disease;   Evaporative Dry Eye Disease
Interventions: Drug: Restasis;   Drug: Refresh Endura
4 Recruiting Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Hyaluronic Acid Gel injection;   Drug: Saline injection
5 Not yet recruiting The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.
Conditions: Thyroid Eye Disease;   Ocular Hypertension;   Glaucoma
Interventions: Drug: Prostaglandin Analog;   Drug: Timolol
6 Unknown  Effect of Percutaneous Botulinum Toxin A Injection on Natural Course of Upper Lid Retraction in Thyroid Eye Disease
Condition: Eye Diseases
Intervention: Drug: Botulinum toxin A injection
7 Recruiting The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy
Conditions: Thyroid-associated Ophthalmopathy;   Dry Eye Syndrome
Interventions: Drug: Methylprednisolone;   Drug: Esomeprazole
8 Recruiting Creation of the Biobank Related to Eye Disease
Condition: Eye Diseases
Intervention:
9 Not yet recruiting Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)
Condition: Graves' Ophthalmopathy
Interventions: Drug: Bimatoprost;   Drug: Eye drop solution
10 Not yet recruiting Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues
Condition: Thyroid Associated Ophthalmopathies
Intervention: Drug: bimatoprost 0.03%
11 Recruiting Evaluation and Treatment of People With Eye Diseases
Condition: Eye Diseases
Intervention:
12 Not yet recruiting Selenium in Mild Thyroid Eye Disease in North America
Condition: Thyroid Associated Ophthalmopathies
Interventions: Dietary Supplement: Sodium selenite;   Dietary Supplement: Sugar pill
13 Recruiting The Utility of in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With Dry Eye Disease
Condition: Dry Eye Disease
Interventions: Drug: Lotemax;   Drug: Artificial Tears
14 Not yet recruiting A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease
Condition: Dry Eye Disease
Intervention: Drug: ISV 101
15 Recruiting Ocular Surface Immune Response in Dry Eye Disease: Analysis of Conjunctival and Peripheral Corneal Immune Cell Alterations by In Vivo Confocal Microscopy and Clinical Correlation
Condition: Dry Eye Disease
Intervention: Other: In vivo confocal microscopy (IVCM)
16 Unknown  The Role of TSH Receptor, PPAR-r, IGF-1R, IGF and Cytokines in Different Stages of Graves’Ophthalmopathy
Condition: Graves' Ophthalmopathy
Intervention:
17 Unknown  Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections
Condition: Thyroid-associated Ophthalmopathy
Intervention: Drug: subconjunctival triamcinolone injection
18 Recruiting Phase 3 Study of EBI-005 in Dry Eye Disease
Condition: Dry Eye Disease (DED)
Interventions: Drug: Active Comparator EBI-005;   Drug: Placebo Comparator
19 Recruiting Tissue Studies of Human Eye Diseases
Conditions: Conjunctival Disease;   Corneal Disease;   Eye Disease;   Uveitis;   Vitreoretinopathy, Proliferative
Intervention:
20 Recruiting Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration
Conditions: Macular Degeneration;   Wet Macular Degeneration;   Retinal Degeneration;   Retinal Diseases;   Eye Diseases
Intervention: Drug: Aflibercept

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years